Two studies on the synthesis of radiopharmaceuticals using 131I-conjugated PD-L1 antibodies have demonstrated that these radiotherapeutic agents can induce ferroptosis in tumor cells (36, 37). The gene discussed is CD274; the disease is neoplasm.